The Prognostic Value of Whole-Blood PSMB5, CXCR4, POMP, and RPL5 mRNA Expression in Patients with Multiple Myeloma Treated with Bortezomib

SIMPLE SUMMARY: The mRNA expression of nine previously described genes that may affect resistance to multiple myeloma (MM), viz., ABCB1, CXCR4, MAF, MARCKS, POMP, PSMB5, RPL5, TXN, and XBP1, was compared between bortezomib-refractory and bortezomib-sensitive patients. RPL5 was the only gene to be si...

Descripción completa

Detalles Bibliográficos
Autores principales: Robak, Pawel, Jarych, Dariusz, Mikulski, Damian, Dróżdż, Izabela, Węgłowska, Edyta, Kotkowska, Aleksandra, Misiewicz, Małgorzata, Smolewski, Piotr, Stawiski, Konrad, Fendler, Wojciech, Szemraj, Janusz, Robak, Tadeusz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7956525/
https://www.ncbi.nlm.nih.gov/pubmed/33668794
http://dx.doi.org/10.3390/cancers13050951

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7956525/
https://www.ncbi.nlm.nih.gov/pubmed/33668794
http://dx.doi.org/10.3390/cancers13050951

Ejemplares similares